hepatitis B

Showing 10 posts of 10 posts found.

GSK enters agreement for license for JNJ-3089 for development of bepirovirsen

November 2, 2023
Medical Communications Arrowhead Pharmaceuticals, GSK, Infections and infestations, Janssen, hepatitis B

GSK and Arrowhead Pharmaceuticals have announced that they have come to an agreement with Janssen Pharmaceuticals, a Johnson & Johnson …

First patient dosed in phase 1 study for chronic hepatitis B treatment

August 31, 2023
Medical Communications Chronic Diseases, ISA Pharmaceuticals, ISA104, clinical trial, hepatitis B

ISA Pharmaceuticals has announced that the first patient has been dosed in its phase 1 HEB-PEP study, assessing the use …


Dynavax’s hepatitis B vaccine gets EU approval

February 23, 2021
Manufacturing and Production EU, Vaccine, hepatitis B

The European Commission (EC) has granted marketing authorisation Dynavax Technologies Corporation’s HEPLISAV B vaccine for the active immunisation against hepatitis …


Arbutus Biopharma moves to terminate development of chronic hepatitis B therapy after trial failure

October 4, 2019
Medical Communications, Research and Development Arbutus Biopharma, hepatitis B, pharma

Arbutus Biopharma has announced its decision to terminate the development of its oral capsid inhibitor, known as AB-506, in the …


Hep-B vaccine four-year battle for FDA approval is finally won

November 10, 2017
Medical Communications, Sales and Marketing biotech, drugs, dynavax, hepatitis B, pharma, pharmaceutical

Dynavax had said it was the last throw of the dice for its hepatitis B vaccine, Hepislav-B – the data …


Global shortage of hep B vaccine hits UK

August 9, 2017
Manufacturing and Production, Research and Development GSK, MSD, biotech, drugs, hep b, hepatitis B, pharma, pharmaceutical

Only last week it was revealed that the UK would administer all babes with the hepatitis B vaccine to reduce …


FDA warns that certain hepatitis C drugs can have serious side-effects

October 5, 2016
Medical Communications, Research and Development FDA, hepatitis B, hepatitis C

The FDA has issued a warning to patients who are currently taking drugs to treat hepatitis C that they may …


Roche cuts ties with Inovio in hepatitis B development

August 3, 2016
Research and Development Inovio, Roche, hepatitis B

Inovio Pharmaceuticals has announced that it will independently continue development of hepatitis B immunotherapy, INO-1800, after Swiss drugmaker Roche issued …


FDA to review investigational hepatitis B vaccine

April 1, 2016
Medical Communications, Research and Development dynavax, hepatitis B, vaccines

Dynavax Technologies (NASDAQ: DVAX) says the FDA has accepted for review the company’s investigational adult hepatitis B vaccine, HEPLISAV-B. The FDA has set …


Gilead success in late-stage hepatitis B trials

January 5, 2016
Research and Development, Sales and Marketing Gilead, hepatitis B, phase III

Two Phase III trials evaluating Gilead treatments in chronic hepatitis B virus (HBV) infection have met their primary objectives, showing …

Latest content